Veranex Blog

1 min read

Veranex’s Model Assesses EXENT® GAM Assay* Savings in Myeloma Patient Monitoring

The investigational model considered the use of the EXENT® GAM Assay from the Binding Site, part of Thermo Fisher Scientific. This is a mass spectrometry method that may replace current immunofixation testing and may inform the timing of bone...

Read More

7 min read

Top 10 Clinical Data Management Service Providers Transforming Trials in 2025

The clinical research landscape is rapidly evolving, placing increased importance on robust and compliant clinical data management services (CDMS)....

Read More